Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B63a4fdf02c526fd1227cdbc5ce4e102b> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B63a4fdf02c526fd1227cdbc5ce4e102b NCIT_P378 "NCI" @default.
- B63a4fdf02c526fd1227cdbc5ce4e102b type Axiom @default.
- B63a4fdf02c526fd1227cdbc5ce4e102b annotatedProperty IAO_0000115 @default.
- B63a4fdf02c526fd1227cdbc5ce4e102b annotatedSource NCIT_C71758 @default.
- B63a4fdf02c526fd1227cdbc5ce4e102b annotatedTarget "A cancer vaccine consisting of a proprietary, recombinant modified vaccinia Ankara (MVA) viral vector encoding an epitope of human epidermal growth factor receptor 2 (HER2) with potential antineoplastic activity. Upon administration, modified vaccinia Ankara (Bavarian Nordic)-HER2 vaccine may stimulate the host immune system to mount humoral and cytotoxic T lymphocyte responses against HER2-expressing tumor cells, resulting in tumor cell lysis. HER2, also known as ErbB-2, is a tyrosine kinase growth factor receptor and a member of the epidermal growth factor receptor family; it plays a significant role in the pathogenesis of some breast cancers." @default.